Go to search feature Go to content

You need to use a different browser. To be able to use our internet services, you can instead use one of these browsers: Apple Safari, Google Chrome, Microsoft Edge or Mozilla Firefox.

Read more about recommended browsers

10 years and USD 2.5 billion lent in developing countries

Stock photo by Annie Spratt on Unsplash

SEB and its partner Symbiotics have now launched 11 microfinance funds since the start in 2013. The funds have collectively lent 2.5 billion dollars to entrepreneurs in 58 developing countries.

The funds lend to local microfinance institutions who in turn lend small amounts of money to entrepreneurs. Thereby investors get an opportunity to contribute to socioeconomic development while earning a favorable return.

Investors money is locked up for five years, but loans usually mature after 2.5-3 years, enabling the funds to lend the same money twice.

SEB was the first Swedish bank to launch a microfinance fund and has just closed its eleventh one. Currently the active funds have loans outstanding to 20 million entrepreneurs. All funds target professional investors.

The funds have pioneered local currency lending, thereby avoiding pushing the foreign currency risk onto the microfinance institutions or their clients. They lend to small and medium sized enterprises in sectors such as renewable energy, sustainable agriculture, education, and healthcare.

All 11 funds have a strong social impact focus and high diversification in terms of countries, currencies, and end-clients, with a low correlation with other asset classes.

The funds, support the United Nations Sustainable Development Goals and comply with Article 9 of the SFDR regulation, meaning they have sustainability as their objective.

Symbiotics is a leading market access platform for impact investing, dedicated to private markets in developing economies and the advisor to the SEB funds.

“We are honoured to have such a long-standing and fruitful partnership with SEB, which has been instrumental in expanding our global reach and impact,” says Roland Dominicé, CEO of Symbiotics.

The two companies are exploring other opportunities for collaboration going forward.

“We are immensely proud of what we have achieved,” says Håkan Brodin from Institutional Asset Management, a unit in SEB’s Investment Management division.

The funds that have reached maturity have provided an annualised returns of 4-9 per cent during the life of the funds.